When Paxlovid Is ‘Commercialized’ In 2023, Patient Access To The Covid-19 Treatment Will Depend On Insurance Status Regardless of what happens to Paxlovid's price once the drug is commercialized in 2023, a uniquely American situation will emerge in which a person’s access to a potentially life-saving Covid-19 treatment will likely depend on arbitrary features like insurance status, age, and Medicaid-eligibility.